REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,160,000 | -18.8% | 113,060 | -17.7% | 0.00% | -33.3% |
| Q4 2020 | $3,892,000 | +7.4% | 137,337 | -4.7% | 0.00% | 0.0% |
| Q3 2020 | $3,624,000 | +16.6% | 144,135 | +13.2% | 0.00% | 0.0% |
| Q2 2020 | $3,108,000 | +123.4% | 127,282 | +35.4% | 0.00% | +50.0% |
| Q1 2020 | $1,391,000 | -2.7% | 94,000 | +6.7% | 0.00% | +100.0% |
| Q4 2019 | $1,430,000 | +61.2% | 88,100 | +29.1% | 0.00% | 0.0% |
| Q3 2019 | $887,000 | +39.2% | 68,235 | +39.0% | 0.00% | 0.0% |
| Q2 2019 | $637,000 | -21.9% | 49,100 | -5.1% | 0.00% | 0.0% |
| Q1 2019 | $816,000 | -21.7% | 51,755 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,042,000 | +187.8% | 51,755 | +388.3% | 0.00% | 0.0% |
| Q4 2015 | $362,000 | +18.7% | 10,600 | -32.8% | 0.00% | – |
| Q3 2014 | $305,000 | -10.8% | 15,769 | +56.6% | 0.00% | – |
| Q2 2014 | $342,000 | – | 10,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |